Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Hangzhou Phecdamed Co., Ltd.

Clinical trials sponsored by Hangzhou Phecdamed Co., Ltd., explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Completed 2
Sort by
  • New drug TJ0113 tested in healthy people for first time

    Knowledge-focused Completed

    This early-stage trial tested the safety and tolerability of TJ0113 capsules in 130 healthy adults. Participants received either single or multiple doses of the drug or a placebo, and some took it after a high-fat meal. The study measured side effects and how the drug moves throu…

    Phase: PHASE1 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Knowledge-focused

    Last updated Jun 27, 2026 09:03 UTC

  • Drug tracking study in healthy men completed

    Knowledge-focused Completed

    This study looked at how a drug called TJ0113 is processed and removed from the body in healthy Chinese men. Six participants took a single dose, and researchers measured the drug in their blood, urine, and stool over time. The goal was to understand how the drug is eliminated, n…

    Phase: PHASE1 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Knowledge-focused

    Last updated Jun 27, 2026 07:58 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space